期刊文献+

2004-2021年我国HIV阳性MSM超额死亡率及其影响因素分析

Excess mortality and influencing factors among HIV-positive men who have sex with men in China,2004-2021
原文传递
导出
摘要 目的了解2004-2021年中国新报告HIV阳性MSM的超额死亡率及其影响因素。方法通过中国疾病预防控制信息系统选取2004-2020年新报告、年龄≥18岁、经男男性行为感染的HIV/AIDS患者。以男性一般人群死亡率为参照,计算HIV阳性MSM的超额死亡率。采用多变量Poisson回归模型并基于相对生存率估计法,进行HIV阳性MSM超额死亡率的影响因素分析。结果2004-2021年HIV阳性MSM的粗死亡率为1.33/100人年,超额死亡率为1.10/100人年。诊断到启动cART时间≤30天和未治疗人群的超额死亡率分别为0.65/100人年和13.85/100人年。随着随访时间的延长,HIV阳性MSM超额死亡率呈现下降趋势。多变量Poisson回归显示,年龄越大、文化程度越低、首次CD4细胞计数水平越低的感染者超额死亡风险越高。此外,居住在中西部省份、未婚/离异/丧偶、医疗机构检测发现、诊断到启动cART时间>30天及未治疗感染者的超额死亡风险较高。结论HIV阳性MSM的死亡风险高于男性一般人群,启动cART治疗可有助于缩小这一死亡率差距。应持续扩大HIV检测范围,尽早发现并及时启动抗病毒治疗,同时提高对老年及文化程度较低MSM的随访服务质量,并加强依从性教育,以全面降低HIV阳性MSM的死亡率。 Objective This study aims to evaluate the excess mortality rates and their influencing factors among newly reported HIV-positive men who have sex with men(MSM)in China from 2004 to 2021.Methods Data of MSM aged≥18 years,diagnosed as HIV positive,infected through male-to-male sexual behavior,and newly reported between 2004 and 2020 were obtained from the China Information System for Disease Control and Prevention.The excess mortality rates for HIV-positive MSM were calculated using the mortality rates of the general male population as a reference.The factors influencing the excess mortality rates among HIV-positive MSM were analyzed using a multivariable Poisson regression model based on the relative survival estimation method.Results From 2004 to 2021,the crude mortality rate for HIV-positive MSM was 1.33/100 person-years and the excess mortality rate was 1.10/100 person-years.The excess mortality rate was 0.65/100 person-years for diagnosed MSM who initiated combination antiretroviral therapy(cART)within 30 days,and 13.85/100 person-years for the untreated population.Subsequently,there was a decreasing trend in the excess mortality rates among HIV-positive MSM with the increasing follow-up period.Multivariable Poisson regression indicated that higher excess mortality risk among HIV-positive MSM was associated with older age,lower educational level,and lower initial CD4+cell count.In addition,HIV-positive MSM residing in central or western provinces,with marital status of unmarried/divorced/widowed,detected by medical institutions,with time from diagnosis to cART initiation>30 days or untreated had a higher risk of excess mortality.Conclusions The mortality risk of HIV-positive MSM is higher than that of the general male population.Initiation of cART may help to narrow the mortality gap.It is of the utmost importance to continuously expand the scope of HIV testing,detect infections earlier,and initiate antiretroviral treatment without delay.Furthermore,it is essential to improve the quality of follow-up services for older individuals.
作者 王实 陈方方 金怡晨 秦倩倩 蔡畅 汤后林 吕繁 WANG Shi;CHEN Fangfang;JIN Yichen;QIN Qianqian;CAI Chang;TANG Houlin;LYU Fan(National Center for AIDS/STD Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102206,China;National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases,National Center for AIDS/STD Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102206,China)
出处 《中国艾滋病性病》 CAS CSCD 北大核心 2024年第5期475-480,共6页 Chinese Journal of Aids & STD
关键词 艾滋病病毒感染者/艾滋病患者 男男性行为者 超额死亡率 HIV/AIDS men who have sex with men(MSM) excess mortality rate
  • 相关文献

参考文献10

二级参考文献80

  • 1王吉亮,李凡,倪明健.新疆艾滋病防治历程[J].疾病预防控制通报,2020,0(1):51-55. 被引量:3
  • 2吕繁,张丽芬,王哲,乔晓春,李东民.中国中部地区两县既往有偿献血人群艾滋病回顾性队列研究[J].中华流行病学杂志,2005,26(5):311-313. 被引量:30
  • 3王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:631
  • 4Staszewski S,Morales-Ramirez J,Tashima KT,et al.Efavirenz plus zidovudine and lamivudine,efavirenz plus indinavir,and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults.Study 006 Team[J].N Engl J Med,1999,341 (25):1865-1873.
  • 5Gallant JE,Staszewski S,Pozniak AL,et al.Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviralnaive patients:a 3-year randomized trial[J].JAMA,2004,292 (2):191-201.
  • 6Zhang F,Dou Z,Yu L,et al.The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China[J].Clin Infect Dis,2008,47 (6):825-833.
  • 7Rossi SM,Maluf EC,Carvalho DS,et al.Impact of antiretroviral therapy under different treatment regimens[J].Rev Panam Salud Publica,2012,32 (2):117-123.
  • 8UNAIDS Reference Group on Estimates,Modeling and Projections.Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact:recommendations of the UNAIDS Reference Group on Estimates,Modeling and Projections[J].AIDS,2002,16(9):w1-14.
  • 9Zhang F,Dou Z,Ma Y,et al.Five-year outcomes of the China National Free Antiretroviral Treatment Program[J].Ann Intern Med,2009,151 (4):241-251,W-52.
  • 10Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy:a collaborative re-analysis.Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action.Concerted Action on SeroConversion to AIDS and Death in Europe[J].Lancet,2000,355(9210):1131-1137.

共引文献267

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部